Asthma is a common condition that causes episodic expiratory airflow limitation due to bronchial smooth muscle constriction and airways inflammation resulting in increased respiratory symptoms and acute asthma exacerbations. Patients with severe asthma have relied on either recurrent courses or daily use of...
FASENRA is 1 dose every8 weeks†for eosinophilic asthma —fewer than other treatment options‡ Find Out More About FASENRA Your symptoms may be related to a different type of asthma Take Our Quiz to Learn More Discover the waysyou can save on FASENRA ...
Overview Risks Diagnosis Treatment Management What is moderate or severe persistent asthma?Moderate or severe persistent asthma means you have asthma symptoms every day. You may also need to use your rescue inhaler daily to treat shortness of breath. Your normal activities are affected by wheezing,...
AstraZeneca's Fasenra, which garnered almost $1 billion in sales last year, is a strong contender in the market to treat severe eosinophilic asthma, but tezepelumab would help the company branch out to treat non-eosinophilic patients. "Alongside Fasenra, we ...
Asthma is a common disease, and although its clinical manifestations may be similar among patients, recent research discoveries have shown that it consists of several distinct clinical clusters or phenotypes, each with different underlying molecular pathways yielding different treatment responses. Based on...
Frequency not reported: Asthma, hiccup, atelectasis, hyperventilation Postmarketing reports: Respiratory arrest[Ref]References 1. (2006) "Product Information. Ionsys (fentanyl)." Ortho McNeil Pharmaceutical 2. Sebel PS, Bovill JG (1983) "Fentanyl and convulsions." Anesth Analg, 62, p. 858-9 3....
Interesting, so no food allergies or asthma but definitely some other things like rhinitis and maybe even the seasonal allergies with eye involvement as well. Pam:Right. Dr. Leo:Dr. Simpson, when you think about the pathophysiology of atopic dermatitis, we’ve come a huge, huge way from...
26 Feb 2024 Results studying the impact of dupilumab treatment on total IgE levels in association with the probability of having flares in patients with moderate-to-severe AD, presented at the 2024 Annual Meeting of the American Academy of Allergy, Asthma and Immunology 27 Feb 2023 Results of...
Frequency not reported: Asthmatic attach, bronchial hypersecretion/hypersecretion in upper respiratory passages, chest congestion, dyspnea, excessive sneezing, hoarseness, mucus obstruction of the nasopharynx, nosebleed, pneumonia, rhinorrhea, shortness of breath, yawning Postmarketing reports: Airway obstruc...
39. Settipane RA, Stevenson DD (1989) "Cross sensitivity with acetaminophen in aspirin-sensitive subjects with asthma." J Allergy Clin Immunol, 84, p. 26-33 40. Van Diem L, Grilliat JP (1990) "Anaphylactic shock induced by paracetamol." Eur J Clin Pharmacol, 38, p. 389-90 41. Leun...